Asia-Pacific Osteoarthritis Therapeutics Market
Asia-Pacific Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report, By Anatomy (Knee, Ankle, Hip, Hand, and Spine), By Drug Type (NSAIDs, Viscosupplementation Agents, Corticosteroids, and Analgesics) and Forecast, 2020-2026 Update Available - Forecast 2024-2030
Asia-Pacific osteoarthritis therapeutics market is estimated to grow at a CAGR of 9.3% during the forecast period. Some pivotal factors encouraging the market growth include significant geriatric population base and increasing awareness regarding orthopaedic disorders in the region. As per the United Nations (UN), the percentage of the population aged 65 years or above has nearly doubled in South-Eastern and Eastern Asia, increasing from 6% in 1990 to 11% in 2019. South-Eastern and Eastern Asia have the largest number of older persons which is 261 million. It is followed by Northern America and Europe (more than 200 million) in 2019.
In older adults, osteoarthritis is one of the major causes of chronic disability. Ageing encourages the development of osteoarthritis along with other risk factors. The condition is characterized by an imbalance between anabolic and catabolic activity in the joint and this imbalance is likely caused due to ageing. Therefore, a significant ageing population base is one of the major causes of the rising osteoarthritis cases in the region, which in turn, is driving the market growth.
The market is segmented based on anatomy and drug type. Based on anatomy, the market is classified into the knee, ankle, hip, hand, and spine. Based on drug type, the market is segmented into NSAIDs, viscosupplementation agents, corticosteroids, and analgesics. Nonsteroidal anti-inflammatory drugs (NSAIDs) is used for pain treatment. In addition, NSAIDs also support prevent joint damage and painful inflammation. Diclofenac is the most commonly used NSAIDs for osteoarthritis treatment, as it was found to be the potential for physical disability and disease-associated pain. Cipla and Dr Reddy's Laboratories are some providers of Diclofenac for osteoarthritis treatment in the region.
Some key players in the market include Cipla Ltd., Pfizer Inc., GlaxoSmithKline plc, and Sanofi S.A. The market players are using some key strategies to increase their market share. For instance, in August 2020, Dr Reddy's Laboratories declared the launch of over-the-counter Diclofenac Sodium topical gel that is used for the treatment of arthritis pain, in the US market. It is the generic version of Voltaren gel by Novartis Corp. This product launch is an essential part of its analgesics portfolio of OTC products.
Research Methodology
The market study of the Asia-Pacific osteoarthritis therapeutics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in our reports.
Secondary Sources Include
- Financial reports of companies involved in the market.
- Whitepapers, research-papers, and news blogs.
- Company websites and their product catalog.
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
- Asia-Pacific Osteoarthritis Therapeutics Market Research and Analysis by Anatomy
- Asia-Pacific Osteoarthritis Therapeutics Market Research and Analysis by Drug Type
The Report Covers
- Comprehensive research methodology of the Asia-Pacific osteoarthritis therapeutics market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Asia-Pacific osteoarthritis therapeutics market.
- Insights about market determinants which are stimulating the Asia-Pacific osteoarthritis therapeutics market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Country
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Asia-Pacific Osteoarthritis Therapeutics Market by Anatomy
5.1.1. Knee
5.1.2. Ankle
5.1.3. Hip
5.1.4. Hand
5.1.5. Spine
5.2. Asia-Pacific Osteoarthritis Therapeutics Market by Drug Type
5.2.1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
5.2.2. Viscosupplementation Agents
5.2.3. Corticosteroids
5.2.4. Analgesics
6. Regional Analysis
6.1. UK
6.2. INDIA
6.3. JAPAN
6.4. Spain
6.5. Italy
6.6. Rest of Asia-Pacific
7. Company Profiles
7.1. Cipla Ltd.
7.2. Daiichi Sankyo Co., Ltd.
7.3. Dr. Reddy's Laboratories
7.4. GlaxoSmithKline plc
7.5. Hanmi Pharmaceutical Co., Ltd.
7.6. Lupin Ltd.
7.7. Pfizer Inc.
7.8. Sanofi S.A.
7.9. Sun Pharmaceutical Industries Ltd.
7.10. Virchow Biotech Private Ltd.
1. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY ANATOMY, 2019-2026 ($ MILLION)
2. ASIA-PACIFIC KNEE OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
3. ASIA-PACIFIC ANKLE OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
4. ASIA-PACIFIC HIP OSTEOARTHRITIS THERAPEUTICS RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
5. ASIA-PACIFIC HAND OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
6. ASIA-PACIFIC SPINE OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
7. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
8. ASIA-PACIFIC NSAIDs FOR OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
9. ASIA-PACIFIC VISCOSUPPLEMENTATION FOR OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
10. ASIA-PACIFIC CORTICOSTEROIDS FOR OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
11. ASIA-PACIFIC ANALGESICS FOR OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
12. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
13. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY ANATOMY, 2019-2026 ($ MILLION)
14. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
15. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY ANATOMY, 2019-2026 ($ MILLION)
16. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
17. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY ANATOMY, 2019-2026 ($ MILLION)
18. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
19. REST OF ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY ANATOMY, 2019-2026 ($ MILLION)
20. REST OF ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
1. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SHARE BY ANATOMY, 2019 VS 2026 (%)
2. ASIA-PACIFIC KNEE OSTEOARTHRITIS THERAPEUTICS MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
3. ASIA-PACIFIC ANKLE OSTEOARTHRITIS THERAPEUTICS MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
4. ASIA-PACIFIC HIP OSTEOARTHRITIS THERAPEUTICS MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
5. ASIA-PACIFIC HAND OSTEOARTHRITIS THERAPEUTICS MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
6. ASIA-PACIFIC SPINE OSTEOARTHRITIS THERAPEUTICS MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
7. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SHARE BY DRUG TYPE, 2019 VS 2026 (%)
8. ASIA-PACIFIC NSAIDs FOR OSTEOARTHRITIS THERAPEUTICS MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
9. ASIA-PACIFIC VISCOSUPPLEMENTATION FOR OSTEOARTHRITIS THERAPEUTICS MARKET SHARE BY DRUG TYPE, 2019 VS 2026 (%)
10. ASIA-PACIFIC CORTICOSTEROIDS FOR OSTEOARTHRITIS THERAPEUTICS MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
11. ASIA-PACIFIC ANALGESICS FOR OSTEOARTHRITIS THERAPEUTICS MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
12. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
13. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
14. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
15. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
16. REST OF ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2019-2026 ($ MILLION)
